Advanz Pharma Corp Ltd showcases a strong commitment to its values and corporate philosophy. The company believes in fostering innovation, promoting patient-centricity, and delivering high-quality healthcare products. Advanz Pharma Corp Ltd is focused on maximizing patient access to essential medicines, prioritizing research and development, and maintaining robust ethical standards. With an unwavering dedication to integrity and excellence, Advanz Pharma Corp Ltd continuously strives to improve the lives of individuals worldwide through its exceptional pharmaceutical solutions.

Advanz Pharma Corp Ltd is primarily present in several key countries and regions globally. The company has a significant presence and operations in countries like the United States, Canada, United Kingdom, Germany, France, Spain, Italy, Australia, and New Zealand. Additionally, Advanz Pharma Corp Ltd has a strong market presence in various regions across Asia, including India, China, Japan, and South Korea. With a diverse presence across multiple countries and regions, the company leverages its global footprint to deliver high-quality pharmaceutical products and solutions to patients around the world.

Advanz Pharma Corp Ltd has achieved several significant milestones. Firstly, the company successfully expanded its global footprint by establishing a strong presence in more than 90 countries. Secondly, Advanz Pharma Corp Ltd received numerous regulatory approvals for its high-quality and affordable generic pharmaceutical products, enhancing accessibility to healthcare worldwide. Additionally, the company consistently focuses on research and development, leading to the introduction of innovative therapies and treatment options. Furthermore, Advanz Pharma Corp Ltd has demonstrated strong financial growth and stability, with consistent revenue generation and shareholder value creation. These milestones highlight Advanz Pharma Corp Ltd's commitment to making a positive impact on global healthcare by delivering high-quality and cost-effective pharmaceutical solutions.

Advanz Pharma Corp Ltd is a renowned pharmaceutical company with a rich history and significant background. Established in [year], Advanz Pharma has continuously evolved over the years to become a leader in the pharmaceutical industry. With a focus on innovation, quality, and customer satisfaction, the company has a proven track record of delivering high-quality products and services. Advanz Pharma's commitment to research, development, and growth has propelled them to the forefront of the industry. With a global presence and a dedicated team of professionals, Advanz Pharma Corp Ltd is dedicated to improving healthcare outcomes and enhancing the quality of life for patients worldwide.

The main competitors of Advanz Pharma Corp Ltd in the market include leading pharmaceutical companies such as Pfizer, Novartis, Johnson & Johnson, and GlaxoSmithKline. These companies are renowned for their strong presence and global reach in the pharmaceutical industry. As Advanz Pharma Corp Ltd operates in this competitive market, it strives to differentiate itself through its unique product offerings, advanced research and development, and strategic partnerships. With its innovative approach and dedication to providing high-quality healthcare solutions, Advanz Pharma Corp Ltd continues to compete with its esteemed counterparts in the pharmaceutical sector.

Advanz Pharma Corp Ltd is primarily active in the pharmaceutical industry.

The business model of Advanz Pharma Corp Ltd focuses on the development, manufacturing, and distribution of specialty pharmaceutical products. The company primarily operates in the global generic and specialty pharmaceutical markets. Advanz Pharma Corp Ltd is committed to providing affordable and high-quality medicines to patients worldwide. With a wide range of products, it aims to address diverse therapeutic areas such as central nervous system disorders, oncology, and cardiovascular diseases. Through its strategic partnerships, Advanz Pharma Corp Ltd ensures a robust supply chain and maintains a strong global presence in the pharmaceutical industry.

Το Ρ/Ε δεν μπορεί να υπολογιστεί αυτή τη στιγμή για το Advanz Pharma Corp.

Το KUV δεν μπορεί να υπολογιστεί αυτή τη στιγμή για Advanz Pharma Corp.

Ο AlleAktien Qualitätsscore δεν μπορεί να υπολογιστεί αυτή τη στιγμή για Advanz Pharma Corp.

Τα έσοδα δεν μπορούν να υπολογιστούν επί του παρόντος για Advanz Pharma Corp.

Τα κέρδη για τον Advanz Pharma Corp δεν μπορούν να υπολογιστούν αυτή τη στιγμή.

Advanz Pharma Corp Ltd is a global healthcare company specializing in the development and marketing of generic and specialized pharmaceutical products. The company operates in various business sectors and pursues a diversified business model to strengthen its position as one of the leading players in the pharmaceutical products industry.

Η Advanz Pharma Corp καταβάλλει μια διανομή της τάξεως των 0 USD διαμοιρασμένη σε δόσεις ετησίως.

Το μέρισμα δεν μπορεί να υπολογιστεί για το Advanz Pharma Corp αυτή τη στιγμή ή η εταιρεία δεν διανέμει μέρισμα.

Ο αριθμός ISIN της Advanz Pharma Corp είναι JE00BJVH6L55.

Το WKN της Advanz Pharma Corp είναι A2PYQF.

Ο τίκερ της Advanz Pharma Corp είναι CXRXF.

Κατά τους τελευταίους 12 μήνες η Advanz Pharma Corp κατέβαλε μια μέρισμα ύψους 67,50 USD . Αυτό αντιστοιχεί σε απόδοση μερίσματος περίπου 395,66 %. Για τους επόμενους 12 μήνες, η Advanz Pharma Corp προβλέπεται να πληρώσει μέρισμα 0 USD.

Η απόδοση μερίσματος της Advanz Pharma Corp ανέρχεται σήμερα στο 395,66 %.

Advanz Pharma Corp πληρώνει τέταρτον διανεμητέου μισθό. Αυτή καταβάλλεται τους μήνες Νοεμβρίου, Φεβρουαρίου, Μαΐου, Αυγούστου.

Η Advanz Pharma Corp πλήρωσε κάθε χρόνο μέρισμα μέσα στα τελευταία 0 έτη.

Για τους επόμενους 12 μήνες αναμένονται μερίσματα σε ύψος των 0 USD. Αυτό αντιστοιχεί σε απόδοση μερίσματος 0 %.

Το Advanz Pharma Corp ανατίθεται στον τομέα 'Υγεία'.

Για να λάβεις το τελευταίο μέρισμα των Advanz Pharma Corp από την 29/7/2016 με τιμή 0,075 USD, έπρεπε να έχεις τη μετοχή στο χαρτοφυλάκιο σου πριν από την ημέρα Ex-Tag στις 13/7/2016.

Η τελευταία μερίσματος έγινε στις 29/7/2016.

Το έτος 2023, η Advanz Pharma Corp διένειμε 0 USD ως μερίσματα.

Τα μερίσματα του Advanz Pharma Corp καταβάλλονται σε USD.